608 related articles for article (PubMed ID: 26834159)
21. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
22. Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment.
Mornex F; Girard N; Delpero JR; Partensky C
Semin Radiat Oncol; 2005 Oct; 15(4):226-34. PubMed ID: 16183476
[TBL] [Abstract][Full Text] [Related]
23. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
[TBL] [Abstract][Full Text] [Related]
24. Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.
Kang CM; Hwang HK; Choi SH; Lee WJ
Surg Oncol; 2013 Jun; 22(2):123-31. PubMed ID: 23518243
[TBL] [Abstract][Full Text] [Related]
25. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
26. New developments in the management of borderline resectable pancreatic cancer.
Sharma J; Ng J; Goodman MD; Saif MW
JOP; 2013 Mar; 14(2):123-5. PubMed ID: 23474551
[TBL] [Abstract][Full Text] [Related]
27. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Parikh PJ; Lee P; Low DA; Kim J; Mittauer KE; Bassetti MF; Glide-Hurst CK; Raldow AC; Yang Y; Portelance L; Padgett KR; Zaki B; Zhang R; Kim H; Henke LE; Price AT; Mancias JD; Williams CL; Ng J; Pennell R; Pfeffer MR; Levin D; Mueller AC; Mooney KE; Kelly P; Shah AP; Boldrini L; Placidi L; Fuss M; Chuong MD
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):799-808. PubMed ID: 37210048
[TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.
Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy for resectable and advanced pancreatic cancer.
Berlin JD; Rothenberg M
Oncology (Williston Park); 2001 Oct; 15(10):1241-9, 1254; discussion 1254-64. PubMed ID: 11702956
[TBL] [Abstract][Full Text] [Related]
31. [Surgical therapy of locally advanced and primary inoperable pancreatic carcinoma after neoadjuvant preoperative radiochemotherapy].
Rau HG; Wichmann MW; Wilkowski R; Heinemann V; Sackmann M; Helmberger T; Dühmke E; Schildberg FW
Chirurg; 2002 Feb; 73(2):132-7. PubMed ID: 11974476
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
33. Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma.
Boone BA; Steve J; Zenati MS; Hogg ME; Singhi AD; Bartlett DL; Zureikat AH; Bahary N; Zeh HJ
Ann Surg Oncol; 2014 Dec; 21(13):4351-8. PubMed ID: 25092157
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.
Tempero MA; Malafa MP; Behrman SW; Benson AB; Casper ES; Chiorean EG; Chung V; Cohen SJ; Czito B; Engebretson A; Feng M; Hawkins WG; Herman J; Hoffman JP; Ko A; Komanduri S; Koong A; Lowy AM; Ma WW; Merchant NB; Mulvihill SJ; Muscarella P; Nakakura EK; Obando J; Pitman MB; Reddy S; Sasson AR; Thayer SP; Weekes CD; Wolff RA; Wolpin BM; Burns JL; Freedman-Cass DA
J Natl Compr Canc Netw; 2014 Aug; 12(8):1083-93. PubMed ID: 25099441
[TBL] [Abstract][Full Text] [Related]
35. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
[TBL] [Abstract][Full Text] [Related]
36. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?
Kim HJ; Czischke K; Brennan MF; Conlon KC
J Gastrointest Surg; 2002; 6(5):763-9. PubMed ID: 12399067
[TBL] [Abstract][Full Text] [Related]
37. A Systematic Review of Chemotherapeutic Regimens Used in Pancreatic Cancer.
Awais N; Satnarine T; Ahmed A; Haq A; Patel D; Hernandez GN; Seffah KD; Zaman MA; Khan S
Cureus; 2023 Oct; 15(10):e46630. PubMed ID: 37937003
[TBL] [Abstract][Full Text] [Related]
38. Management of borderline and locally advanced pancreatic cancer: where do we stand?
He J; Page AJ; Weiss M; Wolfgang CL; Herman JM; Pawlik TM
World J Gastroenterol; 2014 Mar; 20(9):2255-66. PubMed ID: 24605025
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy in pancreatic adenocarcinoma.
Squadroni M; Fazio N
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):386-94. PubMed ID: 20496553
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression.
Dudeja V; Greeno EW; Walker SP; Jensen EH
HPB (Oxford); 2013 Sep; 15(9):661-7. PubMed ID: 23458352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
